Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SHC · against 246 other Healthcare companies of similar size
Ranked #68 of 247 · scores higher than 72% of peers
Bars: peers in each 10-point band of the valuation score18 peers with a valuation score of 70–79, including SHC · Click a bar to see the companies
Mainly thanks to its EBITDA yield, earnings yield and free cash flow yield, which are stronger than most Healthcare peers.
| Metric | SHC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 243 reported | 3.6% | 2.5% | 64% | 30% | |
| EBITDA yieldHigher is better · 244 reported | 8.9% | 4.6% | 79% | 50% | |
| Free cash flow yieldHigher is better · 133 reported | 2.5% | 0.7% | 64% | 20% | |
| Book yieldHigher is better · 245 reported | 14.6% | 26.5% | 27% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 4 | 21.1B HKD (≈$2.7B) | 98 | 67 | |
| 4 | 428.3B JPY (≈$2.9B) | 98 | 59 | |
| 65 | 23.8B CNY (≈$3.3B) | 71 | 54 | |
| 65 | 47.8B HKD (≈$6.1B) | 71 | 58 | |
| 65 | 1.17T JPY (≈$8.0B) | 71 | 58 | |
| 68 | 3.2B EUR (≈$3.6B) | 70 | 61 | |
| 68 | 4.6B USD | 70 | 61 | |
| 68 | 2.3B USD | 70 | 67 | |
| 71 | 2.4B EUR (≈$2.6B) | 69 | 69 | |
| 71 | 9.0B USD | 69 | 57 | |
| 71 | 4.8B USD | 69 | 52 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score